半乳糖凝集素治療公司
US ˙ NasdaqCM ˙ US3632252025

簡介

本頁面提供了有關 Joel Lewis 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Joel Lewis已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:GALT / Galectin Therapeutics Inc. President and CEO, Director 776,260
如何解讀這些圖表

以下圖表顯示了在Joel Lewis進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

GALT / Galectin Therapeutics Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 GALT / Galectin Therapeutics Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2024-04-24 GALT LEWIS JOEL 1,000 3.3900 1,000 3.3900 3,390 5 3.6000 210 6.19
2023-02-16 GALT LEWIS JOEL 1,000 1.5200 1,000 1.5200 1,520
2019-05-31 GALT LEWIS JOEL 12,849 4.2800 12,849 4.2800 54,994
2019-04-05 GALT LEWIS JOEL 667 4.8187 667 4.8187 3,214
2019-02-07 GALT LEWIS JOEL 1,000 4.4841 1,000 4.4841 4,484
2019-01-29 GALT LEWIS JOEL 1,000 4.8050 1,000 4.8050 4,805
2018-06-25 GALT LEWIS JOEL 1,000 7.0584 1,000 7.0584 7,058

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

GALT / Galectin Therapeutics Inc. Insider Trades
GALT / Galectin Therapeutics Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 GALT / Galectin Therapeutics Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

GALT / Galectin Therapeutics Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Joel Lewis 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-01-13 2026-01-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
-56,332 776,260 -6.77 3.88 -218,568 3,011,889
2026-01-06 2026-01-06 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -37,698 832,592 -4.33 3.58 -134,853 2,978,348
2026-01-06 2026-01-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -27,731 870,290 -3.09 3.91 -108,342 3,400,136
2026-01-06 2026-01-02 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -18,571 898,021 -2.03 4.20 -77,939 3,768,815
2026-01-06 2026-01-02 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise 84,000 916,592 10.09
2025-12-19 2025-12-17 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -7,829 832,592 -0.93 7.06 -55,241 5,874,769
2025-12-19 2025-12-17 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 7,829 840,421 0.94 2.86 22,391 2,403,604
2025-11-19 2025-11-18 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -6,783 832,592 -0.81 6.15 -41,723 5,121,357
2025-11-19 2025-11-18 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 6,783 839,375 0.81 2.39 16,211 2,006,106
2025-11-19 2025-11-17 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -15,680 832,592 -1.85 6.04 -94,643 5,025,442
2025-11-19 2025-11-17 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 15,680 848,272 1.88 2.39 37,475 2,027,370
2025-11-12 2025-11-10 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -1,867 832,592 -0.22 6.03 -11,252 5,017,949
2025-11-12 2025-11-10 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 1,867 834,459 0.22 2.39 4,462 1,994,357
2025-11-07 2025-11-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -200 832,592 -0.02 6.00 -1,200 4,995,552
2025-11-07 2025-11-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 200 832,792 0.02 2.39 478 1,990,373
2025-11-05 2025-11-04 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -14,420 832,592 -1.70 6.07 -87,529 5,053,833
2025-11-05 2025-11-04 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 14,420 847,012 1.73 2.39 34,464 2,024,359
2025-11-05 2025-11-03 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -1,300 832,592 -0.16 6.01 -7,813 5,003,878
2025-11-05 2025-11-03 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 1,300 833,892 0.16 2.39 3,107 1,993,002
2025-09-15 2025-09-12 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -14,000 832,592 -1.65 6.36 -89,048 5,295,785
2025-09-15 2025-09-12 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise X 14,000 846,592 1.68 2.39 33,460 2,023,355
2025-03-05 2025-03-03 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award -56,420 832,592 -6.35 1.57 -88,579 1,307,169
2024-12-26 2024-12-23 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
S - Sale X -56,000 897,012 -5.88 0.89 -49,610 794,663
2024-12-26 2024-12-23 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise 56,000 953,012 6.24
2024-04-25 2024-04-24 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 1,000 2,000 100.00 3.39 3,390 6,780
2024-03-04 2024-03-01 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award -152,584 897,716 -14.53 1.96 -299,065 1,759,523
2024-01-02 2023-12-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,606 1,042,300 1.13 1.66 19,266 1,730,218
2023-12-18 2023-12-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,042 1,030,694 1.18 1.60 19,267 1,649,110
2023-12-01 2023-11-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,880 1,018,652 0.98 1.95 19,266 1,986,371
2023-11-15 2023-11-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,303 1,008,772 1.03 1.87 19,267 1,886,404
2023-10-31 2023-10-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,444 998,469 0.95 2.04 19,266 2,036,877
2023-10-16 2023-10-13 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,035 989,025 1.03 2.01 20,170 1,987,940
2023-10-16 2023-10-13 4/A GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,585 989,025 0.98 2.01 19,266 1,987,940
2023-10-02 2023-09-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,035 979,440 1.04 1.92 19,267 1,880,525
2023-09-18 2023-09-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,947 969,405 1.14 1.76 19,267 1,706,153
2023-09-01 2023-08-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,010 958,458 1.16 1.75 19,268 1,677,302
2023-08-15 2023-08-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,042 947,448 1.29 1.60 19,267 1,515,917
2023-07-31 2023-07-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,844 935,406 1.39 1.50 19,266 1,403,109
2023-07-17 2023-07-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,820 922,562 1.30 1.63 19,267 1,503,776
2023-07-03 2023-06-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,380 911 -107.30 1.44 19,267 1,311
2023-06-16 2023-06-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,196 897,362 1.49 1.46 19,266 1,310,149
2023-06-01 2023-05-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,272 884,166 1.41 1.57 19,267 1,388,141
2023-05-16 2023-05-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,748 871,894 1.37 1.64 19,267 1,429,906
2023-05-09 2023-04-28 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,947 860,146 1.29 1.76 19,267 1,513,857
2023-04-17 2023-04-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,585 849,199 1.14 2.01 19,266 1,706,890
2023-04-03 2023-03-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,175 839,614 1.10 2.10 19,268 1,763,189
2023-03-16 2023-03-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,140 830,439 1.24 1.90 19,266 1,577,834
2023-03-02 2023-03-01 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
F - Taxes -75,529 820,299 -8.43 2.07 -156,345 1,698,019
2023-03-02 2023-02-28 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,308 895,828 1.05 2.07 19,268 1,854,364
2023-02-21 2023-02-16 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 1,000 1,000 1.52 1,520 1,520
2023-02-15 2023-02-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,380 886,520 1.53 1.44 19,267 1,276,589
2023-02-07 2023-02-07 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 143,836 873,140 19.72 1.43 205,685 1,248,590
2023-01-31 2023-01-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 15,086 729,304 2.11 1.16 17,500 845,993
2023-01-17 2023-01-13 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 15,351 714,218 2.20 1.14 17,500 814,209
2023-01-03 2022-12-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 15,487 698,867 2.27 1.13 17,500 789,720
2022-12-15 2022-12-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 15,086 683,380 2.26 1.16 17,500 792,721
2022-12-01 2022-11-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,780 668,294 2.11 1.27 17,501 848,733
2022-11-15 2022-11-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 14,113 654,514 2.20 1.24 17,500 811,597
2022-11-01 2022-10-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,681 640,401 2.02 1.38 17,500 883,753
2022-10-17 2022-10-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,802 627,720 1.75 1.62 17,499 1,016,906
2022-10-03 2022-09-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,736 616,918 1.77 1.79 19,217 1,104,283
2022-10-03 2022-09-30 4/A GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,736 616,918 1.77 1.63 17,500 1,005,576
2022-09-15 2022-09-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,777 606,182 1.64 1.79 17,501 1,085,066
2022-09-01 2022-08-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,211 596,405 1.57 1.90 17,501 1,133,170
2022-08-15 2022-08-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 8,028 587,194 1.39 2.18 17,501 1,280,083
2022-08-01 2022-07-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,606 552,139 1.96 2.26 23,970 1,247,834
2022-08-01 2022-07-29 4/A GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,743 552,139 1.42 2.26 17,499 1,247,834
2022-07-18 2022-07-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,606 544,396 1.99 1.65 17,500 898,253
2022-07-01 2022-06-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,359 533,790 2.57 1.31 17,500 699,265
2022-06-16 2022-06-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,780 520,431 2.72 1.29 17,776 671,356
2022-06-01 2022-05-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 13,566 506,651 2.75 1.29 17,500 653,580
2022-05-16 2022-05-13 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 12,868 493,085 2.68 1.36 17,500 670,596
2022-05-02 2022-04-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,290 480,217 2.41 1.55 17,500 744,336
2022-04-18 2022-04-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,057 468,927 2.19 1.74 17,499 815,933
2022-03-31 2022-03-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,870 458,870 2.43 1.61 17,501 738,781
2022-03-16 2022-03-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 10,057 448,000 2.30 1.74 17,499 779,520
2022-03-01 2022-02-28 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 9,358 438 -104.91 1.87 17,499 819
2022-02-15 2022-02-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 8,454 428,585 2.01 2.07 17,500 887,171
2022-02-01 2022-01-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 112,263 420,131 36.46 1.93 216,668 810,853
2022-01-25 2022-01-24 4 GALT GALECTIN THERAPEUTICS INC
Stock Option (right to buy)
A - Award 70,000 70,000
2022-01-18 2022-01-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 8,251 307,868 2.75 2.02 16,667 621,893
2022-01-03 2021-12-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 8,052 299,617 2.76 2.07 16,668 620,207
2021-12-15 2021-12-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,407 291,565 2.61 2.25 16,666 656,021
2021-12-01 2021-11-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,337 284,158 2.28 2.63 16,666 747,336
2021-11-15 2021-11-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 5,828 277,821 2.14 2.86 16,668 794,568
2021-11-01 2021-10-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 5,258 271,993 1.97 3.17 16,668 862,218
2021-10-18 2021-10-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,946 266,735 1.89 3.37 16,668 898,897
2021-09-30 2021-09-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,296 261,789 1.67 3.88 16,668 1,015,741
2021-09-16 2021-09-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,468 257,493 1.77 3.73 16,666 960,449
2021-09-01 2021-08-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,241 253,025 1.70 3.93 16,667 994,388
2021-08-16 2021-08-13 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,931 248,784 2.02 3.38 16,667 840,890
2021-08-02 2021-07-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,061 243,853 2.55 2.75 16,668 670,596
2021-07-16 2021-07-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,435 237,792 2.78 2.59 16,667 615,881
2021-07-02 2021-06-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 5,208 231,357 2.30 3.20 16,666 740,342
2021-06-16 2021-06-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,762 226,149 2.15 3.50 16,667 791,522
2021-06-01 2021-06-01 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 4,198 221,387 1.93 3.97 16,666 878,906
2021-05-17 2021-05-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 3,940 217,189 1.85 4.23 16,666 918,709
2021-05-03 2021-04-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 3,771 213,249 1.80 4.42 16,668 942,561
2021-04-16 2021-04-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,474 209,478 3.70 2.23 16,667 467,136
2021-03-31 2021-03-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,680 202,004 3.95 2.17 16,666 438,349
2021-03-29 2021-03-25 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 140,000 140,000
2021-03-29 2021-03-25 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 70,000 70,000
2021-03-16 2021-03-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,667 194,324 3.55 2.50 16,668 485,810
2021-03-08 2021-03-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 27,027 214,684 14.40 2.22 60,000 476,598
2021-03-01 2021-02-26 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,440 187,657 4.13 2.24 16,666 420,352
2021-02-16 2021-02-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,693 180,217 3.86 2.49 16,666 448,740
2021-02-01 2021-01-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 8,503 173,524 5.15 1.96 16,666 340,107
2021-01-19 2021-01-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,610 165,021 4.83 2.19 16,666 361,396
2021-01-05 2020-12-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 7,440 157,411 4.96 2.24 16,666 352,601
2020-12-16 2020-12-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,614 149,971 4.61 2.52 16,667 377,927
2020-12-01 2020-11-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,410 143,357 4.68 2.60 16,666 372,728
2020-11-17 2020-11-13 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,061 136,947 4.63 2.75 16,668 376,604
2020-11-03 2020-10-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,562 130,886 5.28 2.54 16,667 332,450
2020-10-19 2020-10-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 5,807 124,324 4.90 2.87 16,666 356,810
2020-10-02 2020-09-30 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 6,242 118,517 5.56 2.67 16,666 316,440
2020-09-17 2020-09-15 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 5,171 112,275 4.83 2.93 15,151 328,966
2020-09-02 2020-08-31 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 250,000 250,000
2020-02-10 2020-02-09 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
M - Exercise -8,000 54,250 -12.85
2020-02-10 2020-02-09 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
M - Exercise 8,000 107,104 8.07 2.39 19,120 255,979
2020-01-13 2020-01-09 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 40,000 40,000
2020-01-13 2020-01-09 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 20,455 99,104 26.01 2.86 58,501 283,437
2019-06-03 2019-05-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock Purchase Warrant (right to buy)
P - Purchase 42,831 42,831
2019-06-03 2019-05-31 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 12,849 78,649 19.53 4.28 54,994 336,618
2019-04-08 2019-04-05 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 667 65,800 1.02 4.82 3,214 317,070
2019-02-11 2019-02-07 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 1,000 65,133 1.56 4.48 4,484 292,063
2019-01-30 2019-01-29 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 1,000 64,133 1.58 4.80 4,805 308,159
2019-01-18 2019-01-16 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 35,000 35,000
2019-01-18 2019-01-16 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 11,653 63,133 22.64 4.72 55,002 297,988
2018-06-26 2018-06-25 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
P - Purchase 1,000 51,480 1.98 7.06 7,058 363,366
2017-12-18 2017-12-14 4 GALT GALECTIN THERAPEUTICS INC
Stock option (right to buy)
A - Award 62,250 62,250
2017-12-18 2017-12-14 4 GALT GALECTIN THERAPEUTICS INC
Common Stock
A - Award 23,013 50,880 82.58 2.39 55,001 121,603
2017-12-18 3 GALT GALECTIN THERAPEUTICS INC
Common Stock
55,734
2017-12-18 3 GALT GALECTIN THERAPEUTICS INC
Common Stock
55,734
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)